Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Gerald F. Watts

25 ta ish

The University of Western Australia

AkademScholarda batafsil koʻrsatkichlar

  1. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries +26

    MaqolaOchiq kirish20138 iqtibos
    ABI

  2. Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

    Marianne Benn, Gerald F. Watts, Anne Tybjærg‐Hansen +1

    Maqola20125 iqtibos
    ABI

  3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A. Ference, Henry N. Ginsberg, Ian Graham +23

    Sharh maqolaOchiq kirish20175 iqtibos
    ABI

  4. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    Florian Kronenberg, Samia Mora, Erik S.G. Stroes +19

    MaqolaOchiq kirish20225 iqtibos
    ABI

  5. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons +97

    MaqolaOchiq kirish20215 iqtibos
    ABI

  6. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    Albert Wiegman, Samuel S. Gidding, Gerald F. Watts +29

    Sharh maqolaOchiq kirish20154 iqtibos
    ABI

  7. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit

    Jing Pang, Elissa B. Poulter, Damon A. Bell +5

    Maqola20153 iqtibos
    ABI

  8. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

    Antonio J. Vallejo‐Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai +69

    MaqolaOchiq kirish20163 iqtibos
    ABI

  9. Predicting Cardiovascular Events in Familial Hypercholesterolemia

    Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata +20

    MaqolaOchiq kirish20173 iqtibos
    ABI

  10. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

    Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens +97

    MaqolaOchiq kirish20233 iqtibos
    ABI

  11. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    M. Cuchel, Éric Bruckert, H. N. Ginsberg +41

    Maqola20143 iqtibos
    ABI

  12. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

    MaqolaOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos
    ABI

  13. Familial hypercholesterolemia in China: Prevalence and evidence of underdetection and undertreatment in a community population

    Zumin Shi, Baojun Yuan, Dong Zhao +3

    Boshqa20142 iqtibos
    ABI

  14. Prevalence and treatment of familial hypercholesterolaemia in Australian communities

    Gerald F. Watts, Jonathan E. Shaw, Jing Pang +3

    Boshqa20152 iqtibos
    ABI

  15. Familial hypercholesterolaemia: A global call to arms

    Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole +44

    MaqolaOchiq kirish20152 iqtibos
    ABI

  16. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

    Marianne Benn, Gerald F. Watts, Anne Tybjærg‐Hansen +1

    MaqolaOchiq kirish20162 iqtibos
    ABI

  17. Translational Research for Improving the Care of Familial Hypercholesterolemia: The “Ten Countries Study” and Beyond

    Gerald F. Watts, Phillip Y.A. Ding, Peter M. George +17

    Sharh maqolaOchiq kirish20162 iqtibos
    ABI

  18. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

    Pablo Lázaro, Leopoldo Pérez de Isla, Gerald F. Watts +10

    Maqola20172 iqtibos
    ABI

  19. High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies

    Habtamu B. Beyene, Gavriel Olshansky, Alexander Smith +13

    MaqolaOchiq kirish20202 iqtibos
    ABI

  20. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén, M. John Chapman, Ronald M. Krauss +27

    MaqolaOchiq kirish20202 iqtibos
    ABI

  21. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

    Gerald F. Watts, Samuel S. Gidding, Robert A. Hegele +19

    Sharh maqolaOchiq kirish20232 iqtibos
    ABI

  22. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations

    Gerald F. Watts, A. Juniper, Frank van Bockxmeer +3

    Sharh maqola20122 iqtibos
    ABI

  23. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

    Raúl D. Santos, Samuel S. Gidding, Robert A. Hegele +22

    Sharh maqola20162 iqtibos
    ABI

  24. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    Marina Cuchel, Frederick J. Raal, Robert A. Hegele +20

    Maqola20232 iqtibos
    ABI

  25. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas +80

    MaqolaOchiq kirishLipoproteins and Cardiovascular HealthEuropean Heart Journal20251 iqtibos
    ABI